1. Home
  2. BENF vs SHPH Comparison

BENF vs SHPH Comparison

Compare BENF & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BENF
  • SHPH
  • Stock Information
  • Founded
  • BENF 2003
  • SHPH 2012
  • Country
  • BENF United States
  • SHPH United States
  • Employees
  • BENF N/A
  • SHPH N/A
  • Industry
  • BENF Blank Checks
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BENF Finance
  • SHPH Health Care
  • Exchange
  • BENF Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • BENF 2.3M
  • SHPH 2.3M
  • IPO Year
  • BENF N/A
  • SHPH 2022
  • Fundamental
  • Price
  • BENF $0.33
  • SHPH $0.23
  • Analyst Decision
  • BENF
  • SHPH
  • Analyst Count
  • BENF 0
  • SHPH 0
  • Target Price
  • BENF N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • BENF 100.9K
  • SHPH 11.0M
  • Earning Date
  • BENF 07-01-2025
  • SHPH 05-20-2025
  • Dividend Yield
  • BENF N/A
  • SHPH N/A
  • EPS Growth
  • BENF N/A
  • SHPH N/A
  • EPS
  • BENF N/A
  • SHPH N/A
  • Revenue
  • BENF N/A
  • SHPH N/A
  • Revenue This Year
  • BENF N/A
  • SHPH N/A
  • Revenue Next Year
  • BENF N/A
  • SHPH N/A
  • P/E Ratio
  • BENF N/A
  • SHPH N/A
  • Revenue Growth
  • BENF N/A
  • SHPH N/A
  • 52 Week Low
  • BENF $0.22
  • SHPH $0.23
  • 52 Week High
  • BENF $8.96
  • SHPH $4.71
  • Technical
  • Relative Strength Index (RSI)
  • BENF 59.79
  • SHPH 32.28
  • Support Level
  • BENF $0.28
  • SHPH $0.25
  • Resistance Level
  • BENF $0.28
  • SHPH $0.32
  • Average True Range (ATR)
  • BENF 0.03
  • SHPH 0.05
  • MACD
  • BENF 0.01
  • SHPH 0.00
  • Stochastic Oscillator
  • BENF 70.42
  • SHPH 9.22

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: